Company intelligence / Profile preview

Tikkun Olam Hemp

Tel Aviv, Tel Aviv, Israel

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Tikun Olam has pioneered medical cannabis and is among the few companies backed by robust clinical research, with over 30 clinical trials demonstrating efficacy for a range of indications including pain, autoimmune diseases, epilepsy, cancer, and GI conditions.

Therapeutic areas: ImmunologyRheumatologyGastroenterologyNeurologyPsychiatryOncology
Modalities: Botanical drug (medical-grade cannabis)Cannabis extract (oil, tincture, topical, concentrate)
Industry: Biotech

Partnerships

MedMen (California retail/pharmacy partnership)Vidacann (Florida dispensary partnership)

Beyond the preview

Go deeper on Tikkun Olam Hemp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tikkun Olam Hemp.

Explore the full profile